Nathan Wiederhold

95PUBLICATIONS
213CO-AUTHORS
Medical infection agents (incl. prions)Statistical mechanics in chemistryBiologically active moleculesMedical mycologyPlant and fungus systematics and taxonomy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (95)

|Jun 25, 2026
Establishment of epidemiological cutoff values against Fonsecaea monophora, an agent of chromoblastomycosis and cerebral phaeohyphomycosis.

|Jun 24, 2026
Reply to Chen et al., "Methodological considerations for the establishment of epidemiological cutoff values for Sporothrix species using CLSI broth microdilution".

|Jun 04, 2026
Erratum for Wiederhold et al., "The next-generation polyene EL219 is efficacious in an experimental model of central nervous system coccidioidomycosis caused by Coccidioides immitis".

|Jun 04, 2026
Manogepix demonstrates potent in vitro activity against Aspergillus, Coccidioides, Scopulariopsis/Microascus, Rasamsonia, and Purpureocillium species, including strains with in vitro resistance to other antifungals.

|Apr 21, 2026
Prevalence of cyp51A variants in a US collection of Aspergillus fumigatus clinical isolates and comparative analysis of their contribution to triazole antifungal resistance.

|Apr 15, 2026
Closing the gap on antifungal resistance.

Pageof 16

Frequent Collaborators

6 joint publications

Shawn R Lockhart

6 joint publications

George R Thompson

5 joint publications

Thomas F Patterson

5 joint publications

Ashraf S Ibrahim